Sysmex Corp (6869):企業の製品パイプライン分析2018

◆英語タイトル:Sysmex Corp (6869) - Product Pipeline Analysis, 2018 Update
◆商品コード:DATA904C7708
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:59
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD750 ⇒換算¥102,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD1,500 ⇒換算¥204,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥306,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sysmex Corp (Sysmex) is a supplier of medical devices. It researches, develops, manufactures and sells instruments, reagents, and software applications that facilitate health checkups, treatment and disease management. The company offers diagnostic instruments, reagents and laboratory information systems to clinical laboratories for testing. The solutions that the company offers include heamatology, hemostasis, urinalysis analyzers. It conducts research and development at its facilities in Japan, North America and Europe. The company operates along with its subsidiaries in the Americas, Europe, Middle East, Africa and Asia Pacific. Its products are used by medical institutions. Sysmex is headquartered in Hyogo, Japan.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Sysmex Corp
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Sysmex Corp Company Overview 6
Sysmex Corp Company Snapshot 6
Sysmex Corp Pipeline Products and Ongoing Clinical Trials Overview 6
Sysmex Corp – Pipeline Analysis Overview 9
Business Description 9
Sysmex Corp – Key Facts 9
Sysmex Corp – Major Products and Services 10
Sysmex Corp Pipeline Products by Development Stage 11
Sysmex Corp Pipeline Products Overview 14
Blood-based Diagnostic Assay – Cancer 14
Blood-based Diagnostic Assay – Cancer Product Overview 14
Cancer Diagnostic Reagent 15
Cancer Diagnostic Reagent Product Overview 15
Cancer Related Gene Panel Test System 16
Cancer Related Gene Panel Test System Product Overview 16
Cervical Cancer Screening System 17
Cervical Cancer Screening System Product Overview 17
Companion Diagnostic DNA Test 18
Companion Diagnostic DNA Test Product Overview 18
Diagnostic Test Reagent – Dementia 19
Diagnostic Test Reagent – Dementia Product Overview 19
Immunochemistry Test – Bile Duct Cancer 20
Immunochemistry Test – Bile Duct Cancer Product Overview 20
Immunochemistry Test – CK19F 21
Immunochemistry Test – CK19F Product Overview 21
Immunochemistry Test – FSH 22
Immunochemistry Test – FSH Product Overview 22
Immunochemistry Test – HAV Ab 23
Immunochemistry Test – HAV Ab Product Overview 23
Immunochemistry Test – HBc IgM 24
Immunochemistry Test – HBc IgM Product Overview 24
Immunochemistry Test – LH 25
Immunochemistry Test – LH Product Overview 25
Immunochemistry Test – Tg Ab 26
Immunochemistry Test – Tg Ab Product Overview 26
Immunochemistry Test – TPO Ab 27
Immunochemistry Test – TPO Ab Product Overview 27
Immunochemistry Test – TR Ab 28
Immunochemistry Test – TR Ab Product Overview 28
Liquid Biopsy System 29
Liquid Biopsy System Product Overview 29
Methylated DNA Colon Cancer Diagnostic Test 30
Methylated DNA Colon Cancer Diagnostic Test Product Overview 30
Minimally Invasive Postprandial Hyperglycemia Monitoring System 31
Minimally Invasive Postprandial Hyperglycemia Monitoring System Product Overview 31
Multiplex Gene Panel Test 32
Multiplex Gene Panel Test Product Overview 32
Next-Generation Diagnostic Reagents 33
Next-Generation Diagnostic Reagents Product Overview 33
Sysmex UX-2000 Integrated Urinalysis Instrument 34
Sysmex UX-2000 Integrated Urinalysis Instrument Product Overview 34
Sysmex XS-1000i AutoLoader Automated Hematology Analyzer – IG% Assay 35
Sysmex XS-1000i AutoLoader Automated Hematology Analyzer – IG% Assay Product Overview 35
Sysmex XS-1000i Automated Hematology Analyzer – IG% Assay 36
Sysmex XS-1000i Automated Hematology Analyzer – IG% Assay Product Overview 36
UC-3500 37
UC-3500 Product Overview 37
UF-5000 38
UF-5000 Product Overview 38
XW-100 Automated Hematology Analyzer – CLIA 39
XW-100 Automated Hematology Analyzer – CLIA Product Overview 39
Sysmex Corp – Key Competitors 40
Sysmex Corp – Key Employees 41
Sysmex Corp – Key Employee Biographies 42
Sysmex Corp – Locations And Subsidiaries 43
Head Office 43
Other Locations & Subsidiaries 43
Joint Venture 46
Recent Developments 47
Sysmex Corp, Recent Developments 47
Jul 10, 2018: Sysmex Establishes Subsidiary in Egypt and Begins Conducting Direct Sales and Services 47
Jul 02, 2018: OGT expands direct sales and support infrastructure in Europe 47
Jun 13, 2018: First New Zealand Installation Of Sysmex’s Innovative UN-Series At Labtests 47
May 31, 2018: Clinical Evaluation of Sysmex Inostics’ Plasma NGS Liquid Biopsy Technology to Complement Mammography When Screening for Early Stage Breast Cancer Presented at the 2018 ASCO Annual Meeting 48
May 10, 2018: Sysmex Launches New Products in Its System for the Testing of Cancer Lymph Node Metastasis Using the OSNA Method: Gene Amplification Detector RD-200 and LYNOAMP CK19 49
May 09, 2018: Sysmex Announces Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2018 50
May 09, 2018: Sysmex Group Formulates New Long-Term Management Goals 52
May 08, 2018: Sysmex to Establish Bio-Diagnostic Reagent Center 53
Apr 26, 2018: Sysmex to Launch JICA Project in the Republic of Ghana: “Collaboration Program for Disseminating Automated Urinalysis Diagnosis Technology” 54
Apr 24, 2018: Sysmex Obtains Certification under ISO Guide 34, the International Standard for the Competence of Reference Material Producers 55
Appendix 56
Methodology 56
About GlobalData 59
Contact Us 59
Disclaimer 59

List of Tables
Sysmex Corp Pipeline Products and Ongoing Clinical Trials Overview 6
Sysmex Corp Pipeline Products by Equipment Type 7
Sysmex Corp Pipeline Products by Indication 8
Sysmex Corp, Key Facts 9
Sysmex Corp, Major Products and Services 10
Sysmex Corp Number of Pipeline Products by Development Stage 11
Sysmex Corp Pipeline Products Summary by Development Stage 12
Blood-based Diagnostic Assay - Cancer - Product Status 14
Blood-based Diagnostic Assay - Cancer - Product Description 14
Cancer Diagnostic Reagent - Product Status 15
Cancer Diagnostic Reagent - Product Description 15
Cancer Related Gene Panel Test System - Product Status 16
Cancer Related Gene Panel Test System - Product Description 16
Cervical Cancer Screening System - Product Status 17
Cervical Cancer Screening System - Product Description 17
Companion Diagnostic DNA Test - Product Status 18
Companion Diagnostic DNA Test - Product Description 18
Diagnostic Test Reagent - Dementia - Product Status 19
Diagnostic Test Reagent - Dementia - Product Description 19
Immunochemistry Test - Bile Duct Cancer - Product Status 20
Immunochemistry Test - Bile Duct Cancer - Product Description 20
Immunochemistry Test - CK19F - Product Status 21
Immunochemistry Test - CK19F - Product Description 21
Immunochemistry Test - FSH - Product Status 22
Immunochemistry Test - FSH - Product Description 22
Immunochemistry Test - HAV Ab - Product Status 23
Immunochemistry Test - HAV Ab - Product Description 23
Immunochemistry Test - HBc IgM - Product Status 24
Immunochemistry Test - HBc IgM - Product Description 24
Immunochemistry Test - LH - Product Status 25
Immunochemistry Test - LH - Product Description 25
Immunochemistry Test - Tg Ab - Product Status 26
Immunochemistry Test - Tg Ab - Product Description 26
Immunochemistry Test - TPO Ab - Product Status 27
Immunochemistry Test - TPO Ab - Product Description 27
Immunochemistry Test - TR Ab - Product Status 28
Immunochemistry Test - TR Ab - Product Description 28
Liquid Biopsy System - Product Status 29
Liquid Biopsy System - Product Description 29
Methylated DNA Colon Cancer Diagnostic Test - Product Status 30
Methylated DNA Colon Cancer Diagnostic Test - Product Description 30
Minimally Invasive Postprandial Hyperglycemia Monitoring System - Product Status 31
Minimally Invasive Postprandial Hyperglycemia Monitoring System - Product Description 31
Multiplex Gene Panel Test - Product Status 32
Multiplex Gene Panel Test - Product Description 32
Next-Generation Diagnostic Reagents - Product Status 33
Next-Generation Diagnostic Reagents - Product Description 33
Sysmex UX-2000 Integrated Urinalysis Instrument - Product Status 34
Sysmex UX-2000 Integrated Urinalysis Instrument - Product Description 34
Sysmex XS-1000i AutoLoader Automated Hematology Analyzer - IG% Assay - Product Status 35
Sysmex XS-1000i AutoLoader Automated Hematology Analyzer - IG% Assay - Product Description 35
Sysmex XS-1000i Automated Hematology Analyzer - IG% Assay - Product Status 36
Sysmex XS-1000i Automated Hematology Analyzer - IG% Assay - Product Description 36
UC-3500 - Product Status 37
UC-3500 - Product Description 37
UF-5000 - Product Status 38
UF-5000 - Product Description 38
XW-100 Automated Hematology Analyzer - CLIA - Product Status 39
XW-100 Automated Hematology Analyzer - CLIA - Product Description 39
Sysmex Corp, Key Employees 41
Sysmex Corp, Key Employee Biographies 42
Sysmex Corp, Other Locations 43
Sysmex Corp, Subsidiaries 44
Sysmex Corp, Joint Venture 46
Glossary 58

List of Figures
Sysmex Corp Pipeline Products by Equipment Type 7
Sysmex Corp Pipeline Products by Development Stage 11

★海外企業調査レポート[Sysmex Corp (6869):企業の製品パイプライン分析2018]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Jack in the Box Inc (JACK):企業の財務・戦略的SWOT分析
    Jack in the Box Inc (JACK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Petoro AS-石油・ガス分野:企業M&A・提携分析
    Summary Petoro AS (Petoro) is an oil and gas asset management company. The company manages Norwegian state’s direct financial interests (SDFI) in Norwegian Continental Shelf (NCS) oil and gas assets. It has the responsibility for and to attend to the commercial aspects related to the state's direct …
  • Sino Gas & Energy Holdings Ltd (SEH):石油・ガス:M&Aディール及び事業提携情報
    Summary Sino Gas & Energy Holdings Ltd (Sino Gas), a subsidiary of MIE Holdings Corp, is an oil and gas company that explores and develops unconventional gas assets production sharing contracts. The company holds working interest in the Linxing PSC and the Sanjiaobei PSC projects. It has strategic A …
  • Dentsply Sirona, Inc.:戦略・SWOT・企業財務分析
    Dentsply Sirona, Inc. - Strategy, SWOT and Corporate Finance Report Summary Dentsply Sirona, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Group Five Ltd (GRF):企業の財務・戦略的SWOT分析
    Group Five Ltd (GRF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Telekom Austria AG:企業の戦略・SWOT・財務情報
    Telekom Austria AG - Strategy, SWOT and Corporate Finance Report Summary Telekom Austria AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Pharnext SA (ALPHA):企業の財務・戦略的SWOT分析
    Summary Pharnext SA (Pharnext), formerly Pharnext SAS is a biopharmaceutical company that develops novel therapies for severe neurodegenerative diseases. The company offers pleotherapy, a proprietary research and development platform based on network pharmacology that uses wide genomic data to ident …
  • Sernova Corp (SVA):企業の製品パイプライン分析2018
    Summary Sernova Corp (Sernova) is a clinical stage regenerative medicines company which develops and commercializes medical device and combination products for the treatment of chronic diseases. The company develops Cell Pouch System, an implantable medical device, which offers a natural organ-like …
  • Continental Resources, Inc.:企業の戦略・SWOT・財務分析
    Continental Resources, Inc. - Strategy, SWOT and Corporate Finance Report Summary Continental Resources, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • China Construction Bank Corp:企業の戦略・SWOT・財務分析
    China Construction Bank Corp - Strategy, SWOT and Corporate Finance Report Summary China Construction Bank Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Europlasma SA (ALEUP):企業の財務・戦略的SWOT分析
    Europlasma SA (ALEUP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Formosa Laboratories Inc (4746)-製薬・医療分野:企業M&A・提携分析
    Summary Formosa Laboratories Inc (Formosa) is a healthcare products provider that develops ingredients. The company develops and markets active pharmaceutical ingredients and UV filters. Its active pharmaceutical ingredients comprise anticancers, cholesterol and phosphate binders, MRI enhancing agen …
  • Phosphagenics Ltd:企業のM&A・事業提携・投資動向
    Phosphagenics Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Phosphagenics Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • BioArctic AB (BIOA B):製薬・医療:M&Aディール及び事業提携情報
    Summary BioArctic AB (BioArctic), formerly BioArctic Neuroscience AB, is a biopharma company that develops new immunotherapeutic treatments for patients with central nervous system disorders. The company develops drugs for neurological disorders such as Parkinson’s disease, Alzheimer’s disease and s …
  • Continuum Wind Energy Ltd-エネルギー分野:企業M&A・提携分析
    Summary Continuum Wind Energy Ltd (Continuum Wind Energy), a subsidiary of Morgan Stanley Infrastructure Partners LP is a renewable energy company that constructs and develops wind farms and wind energy generation. The company's services include optimization of number of wind turbines to maximize ge …
  • Schuler AG:企業の戦略・SWOT・財務情報
    Schuler AG - Strategy, SWOT and Corporate Finance Report Summary Schuler AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • China Mengniu Dairy Co Ltd:企業の戦略・SWOT・財務情報
    China Mengniu Dairy Co Ltd - Strategy, SWOT and Corporate Finance Report Summary China Mengniu Dairy Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Sinopec Shanghai Petrochemical Company Limited:企業の戦略・SWOT・財務情報
    Sinopec Shanghai Petrochemical Company Limited - Strategy, SWOT and Corporate Finance Report Summary Sinopec Shanghai Petrochemical Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • Blue Apron Inc. (APRN):企業の財務・戦略的SWOT分析
    Blue Apron Inc. (APRN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • The Bank of Kyoto Ltd:企業の戦略・SWOT・財務情報
    The Bank of Kyoto Ltd - Strategy, SWOT and Corporate Finance Report Summary The Bank of Kyoto Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆